Sophisticated
cell targeting systems such as the gene therapy approach developed for senescent cell clearance by Oisin Biotechnologies could also be turned to stem cell or immune cell destruction, given suitable markers of cell chemistry.
Not exact matches
The institute, which includes over 40 laboratories and more than 300 researchers, said the research would focus on modifying a patient's own immune
system T -
cells to
target a tumor, studying ways to boost patient response to current immunotherapy drugs.
The exterior of the nanoparticle is coated with nucleic acids that act as
targeting agents, drawing the delivery
system to the retina and facilitating uptake by RPE
cells.
«Many diseases, especially complex diseases, involve multiple genes, and this
system could be used therapeutically to
target and activate multiple genes together and rescue these disease phenotypes,» says Albert Cheng, a graduate student in the Jaenisch lab and co-author of the
Cell Research paper.
«Current therapies in clinical trials are focused on
targeting genetic changes in tumors and helping to boost one's immune
system to fight the cancer
cells.
«
Targeting the drivers of aging and senescent
cells may be a novel therapeutic strategy to reduce hepatic steatosis and liver fibrosis in ALD patients,» commented co-author Gianfranco Alpini, PhD, Distinguished Professor in the Department of Medical Physiology at Texas A&M College of Medicine, Senior Research Scientist at Central Texas Veterans Health Care
System, and Director of the BSW DDRC.
In reaction to infection or inflammation, immune
system cells known as effector T
cells (Teffs) undergo rapid changes - arming themselves and diversifying into groups that
target specific diseased
cells.
In this study, the SIgN team discovered for the first time that the integrity of p53 affects the production of a special
cell surface protein called Major Histocompatibility Complex (MHC) class I. MHC class I molecules on the cancer
cell surface serve as
targets for the immune
system.
One class of immunotherapeutic drugs is known as «checkpoint» inhibitors, as they
target checkpoints in immune
system regulation to allow the body's natural defenses, such as white blood
cells, to more effectively
target the cancer.
Although the group didn't identify the toxin's
target, it probably causes
cells to die from within by overstimulating the immune
system, says immunologist Harry Hill of the University of Utah.
More importantly, it opens up exciting avenues of research to explore how restoration of p53 with drugs such as those that
target ERAP1 can help to harness the immune
system to recognise and destroy cancer
cells.»
Researchers at Penn State have combined the two approaches by taking biodegradable polymer nanoparticles encapsulated with cancer - fighting drugs and incorporating them into immune
cells to create a smart,
targeted system to attack cancers of specific types.
The protein has long been considered too complex to
target with a drug as it also is crucial to proper function of many immune
system cells, not just B
cells gone bad.
A potential adrenalinelike drug for weight control must
target only the fat -
cell receptors to avoid dangerous side effects in the cardiovascular
system.
«Our study reveals a new mechanism that could be harnessed for biological therapies for lupus and other autoimmune diseases, where the immune
system mistakenly
targets the body's own
cells,» says senior study author Boris Reizis, PhD, professor of Pathology and Medicine at NYU Langone.
The researchers found that HIV spiked into semen was more successful than the virus alone at infecting T
cells and macrophages (immune
system cells that are believed to be the infection's initial
targets in the body).
EMD Serono, Kirschbaum says, «focuses on the development of
targeted cancer therapies on three therapeutic platforms:
targeting the tumor
cell, the tumor environment, and the immune
system.»
This
cell's gene - editing
system targets RNA, revealing the molecule's distribution in the cytoplasm.
Although some cancers — particularly those that are rife with mutations like lung cancer or melanoma — create more tangible
targets on the surface of
cells for the immune
system to recognize and attack, other malignancies such as prostate and pancreatic cancers have proved more intransigent.
My cancer
systems biology team at the University of California, Merced, is tackling diagnosis and treatment of therapy - resistant cancers by elucidating the network of changes within
cells as a way to identify new drug
targets and circumvent cancer resistance.
That makes sense, Swanton says, because if the immune
system targets trunk antigens, it's hitting most of the cancer
cells, rather than «nipping off little branches».
BREAKING DOWN MULTIPLE SCLEROSIS Taking narrow aim at the immune
system isn't enough, so researchers are looking for new treatment
targets within nerve
cells and even in the gut.
Joseph Wu of Stanford University, California, and his team have found that a mouse's immune
system can be primed to recognise and
target cancer
cells by vaccinating them beforehand with stem
cells.
Óscar Llorca and his team have used this technique to learn about the structure and functioning of a complex
system called R2TP, which is involved in various key processes for
cell survival such as the activation of the kinases mTOR, ATR and ATM, proteins that are the
target of various cancer drugs currently being developed.
Beyond lung cancer, TiY is able to
target TICs in 28 types of human
cell lines derived from the central nervous
system, melanoma, breast, renal, ovarian, colon, and prostate cancer.
The virus appears to invade the brain by infecting a type of glial
cell called olfactory ensheathing
cells (OECs), which nourish smell - sensing neurons and guide them from the olfactory bulb to their
targets in the nervous
system.
Using the JEDI technology, Mount Sinai researchers uncovered evidence that immune
cells can find
cells in the brain expressing their
target antigen, even in non-infected states, which provides evidence of an immune surveillance pathway within the body's central nervous
system.
However, the Moffitt scientists suggest that it may be possible to
target the TGF - β - miR183 - DAP12 pathway in patients with lung cancer to activate the immune
system and kill cancer
cells.
Unfortunately, the
cells provided a multitude of new
targets for HIV infection — something that didn't happen in those whose immune
systems had never been exposed to the adenovirus.
The human immune
system wants to produce antibodies that bind to the glycoprotein to stop infection, but the glycans block immune
cells from seeing their
targets and developing useful antibodies.
By manipulating the function of certain immune
cells, called T
cells, researchers could help restore the
system's balance and create new treatments to
target these diseases.
As with innate immunity, the adaptive immune
system — the T
cells and antibodies produced by B
cells that
target specific molecules on invading
cells — contributes to pathology or may also fight against it.
In laboratory studies, daratumumab caused the
targeted killing of CD38 - carrying tumor
cells by several distinct and potent mechanisms, including some that involve the immune
system.
Given the potential for living
systems to produce highly complex chemical compounds, researchers working with Michelle C.Y. Chang at the University of California, Berkeley (USA), aimed to manipulate the biosynthetic machinery in
cells to use simple fluorinated building blocks to make new organofluorine
target molecules.
«
Targeting autophagy in tumor
cells is a promising strategy to reinforce the immune
system to fight cancer,» he claims.
Now, instead of our drugs
targeting only diseased
cells, we can
target the immune
system and provoke
cells of the immune
system to do the job for us,» said E. John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology.
«Research into basic workings of immune
system points to way of improving therapies for cancer: Differences in wiring of «exhausted» and effective T
cells indicate possible gene - editing
targets.»
«The AAV - DJ / 8 subtype combines multiple serotypes, giving us a broader range of
cell targets for the delivery of our CRISPR / Cas9
system,» Dr. Hu said.
Most
cells from a foreign donor, such as in transplanted organs, are
targeted by the immune
system, but «this one has found a way to suppress the immune
system of its hosts long enough to let it be passed along,» he says.
Other vaccines in trials
target the blood -
cell stage, and contain a parasite protein called AMA - 1, meant to prime the body's immune
system to attack it.
Today the brain's serotonin
system is already a known
target for the treatment of depression, and according to researchers it should be possible to use time signals in pharmaceutical development based on stem
cells.
Genetically modified Salmonella bacteria
target tumors and make the immune
system extra aggressive toward cancer
cells.
Cincinnati Cancer Center (CCC) and UC Cancer Institute researchers have found that a vaccine,
targeting tumors that produce a certain protein and receptor responsible for communication between
cells and the body's immune
system, could initiate the immune response to fight cancer.
Researchers in the Departments of Biomedicine and Nephrology at the University Hospital and the University of Basel have discovered that the immune
system uses a molecular biological clock to
target intolerant T
cells during their maturation process.
Implanted devices send
targeted electrical stimulation to the nervous
system to interfere with abnormal brain activity, and it is commonly assumed that neurons are the only important brain
cells that need to be stimulated by these devices.
The prospect of combining genomically
targeted therapies with drugs that free the immune
system to attack cancer suggests «we are finally poised to deliver curative therapies to cancer patients,» researchers at The University of Texas MD Anderson Cancer Center note in a review in the April 9 edition of
Cell.
In this way, the patient's newly educated immune
system would then
target and kill any future
cells that show the same antigens — the real pancreatic cancer
cells.
The two
cell types are important to a broad range of organ
systems in the body and play active roles in diseases that could be
targets for nucleic acid therapies.
The trouble is that the virus
targets not only the lymphocyte
cells, which include T
cells — a key component of the body's immune
system helping to fight diseases — but also other immune
system cells.
Called the CTC - iChip
system (the «i» is for «inertial focusing»), it
targets blood
cells instead of cancer
cells.